MedTrace Logo

The Effect of Sugammadex on the Outcome After Colorectal Cancer Surgery

NCT03619759 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 585

Last updated 2019-08-20

No results posted yet for this study

Summary

This study is retrospective study. The purpose of this study is checking the effect of sugammadex on the outcome after colorectal surgery. The outcome is compared among the 2 groups, sugammadex group and non-sugammadex group. The primary parameters of outcome are length of stay, readmission rate, postoperative complications, time interval for first successful oral intake.

Conditions

  • Outcome, Fatal

Interventions

DRUG

Sugammadex

Sugammadex injection as a reverse agent of neuromuscular blocking

Sponsors & Collaborators

  • Ajou University School of Medicine

    lead OTHER

Principal Investigators

  • In Kyong Yi, MD · Ajou University School of Medicine

Eligibility

Min Age
21 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-22
Primary Completion
2018-08-31
Completion
2018-09-01

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03619759 on ClinicalTrials.gov